HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma

PLoS ONE - United States
doi 10.1371/journal.pone.0169407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

SRC and STAT3 Inhibitors Synergize to Promote Tumor Inhibition in Renal Cell Carcinoma

Oncotarget
Oncology
2015English

Primary Renal Synovial Sarcoma

Clinics and Practice
2012English

EGF Receptor and PKCδ Kinase Activate DNA Damage-Induced Pro-Survival and Pro-Apoptotic Signaling via Biphasic Activation of ERK and MSK1 Kinases

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Primary Mediastinal Synovial Sarcoma

Journal of Lung Cancer
2008English

Primary Retropharyngeal Synovial Sarcoma

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2008English

Targeting Epigenetic Misregulation in Synovial Sarcoma

Cancer Cell
Cancer ResearchOncologyCell Biology
2012English

BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

HDAC Inhibitors in Experimental Liver and Kidney Fibrosis

Fibrogenesis and Tissue Repair
DermatologyMedicineHepatologyRheumatologyGastroenterology
2013English

Treatment of Synovial Sarcoma in Children

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy